Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient Safety During Transport”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Not applicableNot Yet RecruitingNCT07805603
What this trial is testing

HERMES: Quality and Safety of Advanced Respiratory Support During Patient Transport

Who this might be right for
Acute Respiratory FailureRespiratory InsufficiencyRespiratory Distress+11 more
Medipol University 565
Testing effectiveness (Phase 2)Study completedNCT01233284
What this trial is testing

Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma.

Who this might be right for
Asthma
Boehringer Ingelheim 149
Testing effectiveness (Phase 2)Study completedNCT00528996
What this trial is testing

An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 2,080
Early research (Phase 1)Study completedNCT02914171
What this trial is testing

Study of Autologous Bone Marrow Derived Mononuclear Cells for Treatment of Ebstein Anomaly

Who this might be right for
Ebstein Anomaly
Timothy J. Nelson 10
Not applicableStudy completedNCT03848767
What this trial is testing

An Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus During Meal Challenges

Who this might be right for
Type 1 Diabetes Mellitus
Eli Lilly and Company 10
Large-scale testing (Phase 3)Study completedNCT01316380
What this trial is testing

Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 465
Testing effectiveness (Phase 2)Study completedNCT03257995
What this trial is testing

Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.

Who this might be right for
Asthma
Novartis Pharmaceuticals 54
Large-scale testing (Phase 3)Study completedNCT01340209
What this trial is testing

Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 285
Not applicableLooking for participantsNCT07156669
What this trial is testing

Safety and Performance of the Novalung Ultimate Kit and Xenios 2.0 During Stationary Use in Hospital and Ground-based Transport of Patients on Extracorporeal Life Support (ECLS)

Who this might be right for
Cardio-Respiratory FailureExtracorporeal Membrane Oxygenation ComplicationAcute Lung Injury
Xenios AG 20
Not applicableActive Not RecruitingNCT06655207
What this trial is testing

Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage

Who this might be right for
Post Partum HaemorrhageMaternal Care PatternsHigh Risk Pregnancy
Baymatob Operations Pty Ltd 1,000
Not applicableWithdrawnNCT01974128
What this trial is testing

Study to Assess the Safety and Cardiovascular Effects of Autologous Adipose-Derived Stromal Cells Implantation In Patients During the Acute Recovery Phase of ST-Elevation Myocardial Infarction

Who this might be right for
Acute Myocardial Infarction
Ageless Regenerative Institute
Not applicableStudy completedNCT07807189
What this trial is testing

HERMES: International Survey and Portable External Power Evaluation During Respiratory Support Transport

Who this might be right for
Patient TransportRespiratory FailureNoninvasive Ventilation+6 more
Medipol University 246
Early research (Phase 1)WithdrawnNCT02218762
What this trial is testing

A Study in Patients With Moderate Asthma to Compare Pharmacokinetics and Pharmacodynamic Effects of Fluticasone Propionate and Salmeterol Delivered Via the ROTAHALER® Inhaler Relative to the DISKUS® Inhaler

Who this might be right for
Asthma
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT00500812
What this trial is testing

A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord Injuries

Who this might be right for
Spinal Cord Injury
Vertex Pharmaceuticals Incorporated 48
Testing effectiveness (Phase 2)Study completedNCT01229332
What this trial is testing

A Safety, Tolerability and Pharmacokinetic Study of ND0611 on the Top of Different Oral Dosage Forms of Levodopa/Carbidopa in Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
NeuroDerm Ltd. 24
Large-scale testing (Phase 3)Study completedNCT00776984
What this trial is testing

Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)

Who this might be right for
Asthma
Boehringer Ingelheim 453
Large-scale testing (Phase 3)Study completedNCT01172808
What this trial is testing

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma I

Who this might be right for
Asthma
Boehringer Ingelheim 1,071
Large-scale testing (Phase 3)Study completedNCT01172821
What this trial is testing

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma II

Who this might be right for
Asthma
Boehringer Ingelheim 1,032
Testing effectiveness (Phase 2)Study completedNCT01152450
What this trial is testing

A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 94
Large-scale testing (Phase 3)Study completedNCT00850343
What this trial is testing

Long-term Treatment Study of Certolizumab Pegol Without Coadministration of Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Inc 208
Next Page